Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 10
Submit an article Journal homepage
151
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination

Lauren C. Shapiroa Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAORCID Iconhttps://orcid.org/0000-0003-0138-8986View further author information
ORCID Icon,
Astha Thakkara Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Radhika Galia Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Jesus D. Gonzalez-Lugoa Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Abdul-Hamid Bazarbachib Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAORCID Iconhttps://orcid.org/0000-0003-0243-4040View further author information
ORCID Icon,
Shafia Rahmana Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Kith Pradhana Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Karen Fehna Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Michelly Abreua Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Noah Kornbluma Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Kira Gritsmana Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Mendel Goldfingera Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Aditi Shastria Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Ioannis Mantzarisa Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Ira Braunschweiga Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Balazs Halmosa Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Amit Vermaa Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Margaret McCortc Division of Infectious Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
,
Lizamarie Bachier-Rodrigueza Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USAView further author information
&
R. Alejandro Sicaa Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USACorrespondence[email protected]
View further author information
 show all
Pages 2484-2488 | Received 28 Jan 2022, Accepted 04 May 2022, Published online: 20 May 2022

References

  • Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881–2892.
  • Wood WA, Neuberg DS, Thompson JC, et al. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH research collaborative data hub. Blood Adv. 2020;4(23):5966–5975.
  • Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615.
  • Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416.
  • Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of Single-Dose Ad26.COV2.S vaccine against covid-19. N Engl J Med. 2021;384(23):2187–2201.
  • Thakkar A, Gonzalez-Lugo JD, Goradia N, et al. Seroconversion rates following COVID-19 vaccination among patients with cancer. Cancer Cell. 2021;39(8):1081–1090.
  • Addeo A, Shah PK, Bordry N, et al. Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer. Cancer Cell. 2021;39(8):1091–1098.
  • Marra A, Generali D, Zagami P, et al. Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2. Ann Oncol. 2021;32(1):113–119.
  • Herishanu Y, Avivi I, Aharon A, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137(23):3165–3173.
  • Oekelen OV, Gleason CR, Agte S, et al. Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell. 2021;39(8):1028–1029.
  • Vijenthira A, Gong I, Betschel SD, et al. Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients. Blood Adv. 2021;5(12):2624–2643.
  • Dhakal B, Abedin S, Fenske T, et al. Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy. Blood. 2021;138(14):1278–1281.
  • Bradley BT, Bryan A, Fink SL, et al. Anti-SARS-CoV-2 antibody levels are concordant across multiple platforms but are not fully predictive of sterilizing immunity. J Clin Microbiol. 2021;59(9):e0098921.
  • Greenberger LM, Saltzman LA, Senefeld JW, et al. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies. Cancer Cell. 2021;39(8):1031–1033.
  • Logue JM, Zucchetti E, Bachmeier CA, et al. Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma. Haematologica. 2021;106(4):978–986.
  • Yri OE, Torfoss D, Hungnes O, et al. Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood. 2011;118(26):6769–6771.
  • Wadhera RK, Wadhera P, Gaba P, et al. Variation in COVID-19 hospitalizations and deaths across New York city boroughs. JAMA. 2020;323(21):2192–2195.
  • Khubchandani J, Macias Y. COVID-19 vaccination hesitancy in Hispanics and African-Americans: a review and recommendations for practice. Brain Behav Immun Health. 2021;15:100277.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.